High-throughput screening of viral entry inhibitors using pseudotyped virus

Current Protocols in Pharmacology

Volumn , Issue SUPPL.51, 2010, Pages

  Basu, Arnab ^a   Mills, Debra M ^a   Bowlin, Terry L ^a  

^a MICROBIOTIX INC   (United States)

Author keywords

High throughput screen; Lentiviral vectors; Pseudotyped virus

Indexed keywords

ANTIVIRUS AGENT; CELL RECEPTOR; LENTIVIRUS VECTOR; VIRUS GLYCOPROTEIN;

ARTICLE; DRUG SPECIFICITY; EBOLA VIRUS; GENETIC TRANSFECTION; HIGH THROUGHPUT SCREENING; HOST CELL; LASSA VIRUS; LUMINESCENCE; MICROTITER PLATE ASSAY; NONHUMAN; PRIORITY JOURNAL; PSEUDOTYPE VIRUS; SUSPENSION CELL CULTURE; VESICULAR STOMATITIS VIRUS; VIRUS; VIRUS ENTRY;

EID: 79953280350     PISSN: 19348282     EISSN: 19348290     Source Type: Journal    
DOI: 10.1002/0471141755.ph13b03s51     Document Type: Article

References (37)

1. Basu, A., Kanda, T., Beyene, A., Saito, K., Meyer, K., and Ray, R. 2007. Sulfated homologues of heparin inhibit hepatitis c virus entry. J. Virol. 81:3933-3941.
2. Bartosch, B., Dubuisson, J., and Cosset, F.-L. 2003. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197:633-642.
3. Cianci, C, Yu, K.L., Combrink, K., Sin, N., Pearce, B., Wang, A., Civiello, R., Voss, S., Luo, G., Kadow, K., Genovesi, E.V., Venables, B., Gulgeze, H., Trehan, A., James, J., Lamb, L., Medina, I., Roach, J., Yang, Z., Zadjura, L., Colonno, R., Clark, J., Meanwell, N.A., and Krystal, M. 2004. Orally active fusion inhibitor of respiratory syncytial virus. Antimi-crob. Agents Chemother. 48:413-422.
4. Dong, J., Roth, M.G., and Hunter, E. 1992. A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range. J. Virol. 66: 7374-7382.
5. Guo, Y., Rumschlag-Booms, E., Wang, J., Xiao, H., Yu, J., Wang, J., Guo, L., Gao, G.F., Cao, Y., Caffrey, M., and Rong, L. 2009. Analysis of hemagglutinin-mediated entry tropism of H5N1 avian influenza. Virol. J. 6:39.
6. Hatziioannou, T., Valsesia-Wittmann, S., Russell, S., and Cosset, F.-L. 1998. Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses. J. Virol. 72:5313-5317.
7. He, J., Choe, S., Walker, R., Di Marzio, P., Morgan, D.O., and Landau, N.R. 1995. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69:6705-6711.
8. Ito, H., Watanabe, S., Takada, A., and Kawaoka, Y. 2001. Ebola virus glycoprotein: Proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J. Virol. 75:1576-1580.
9. Kobinger, G.P., Weiner, D.J., Yu, Q.C., and Wilson, J.M. 2001. Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat. Biotechnol. 19:225-230.
10. Kocisko, D.A., Baron, G.S., Rubenstein, R., Chen, J., Kuizon, S., and Caughey, B. 2003. New inhibitors of scrapie-associated prion protein formation in a library of 2,000 drugs and natural products. J. Virol. 77:10288-10294.
11. Lagging, L.M., Meyer, K., Owens, R.J., and Ray, R. 1998. Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus. J. Virol. 72:3539-3546.
12. Landau, N.R., Page, K.A., and Littman, D.R. 1991. Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J. Virol. 65:162-169.
13. Larson, R.A., Dai, D., Hosack, V.T., Tan, Y., Bolken, T.C., Hruby, D.E., and Amberg, S.M. 2008. Identification of a broad-spectrum arenavirus entry inhibitor. J. Virol. 82:10768-10775.
14. Lee, A.M., Rojek, J.M., Spiropoulou, C.F., Gundersen, A.T., Jin, W., Shaginian, A., York, J., Nunberg, J.H., Boger, D.L., Oldstone, M.B., and Kunz, S. 2008. Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses. J. Biol. Chem. 283:18734-18742.
15. Lipinski, C.A., Lombardo, F., Dominy, B.W., and Feeney. P.J. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46:3-26.
16. Manicassamy, B., Wang, J., Jiang, H., and Rong, L. 2005. Comprehensive analysis of ebola virus GP1 in viral entry. J. Virol. 79:4793-4805.
17. Manicassamy, B., Wang, J., Rumschlag, E., Tymen, S., Volchkova, V., Volchkov, V., and Rong, L. 2007. Characterization of Marburg virus glycoprotein in viral entry. Virology 358:79-88.
18. Matsuura, Y., Tani, H., Suzuki, K., Kimura-Someya, T., Suzuki, R., Aizaki, H., Ishii, K., Moriishi, K., Robison, C.S., Whitt, M.A., and Miyamura, T. 2001. Characterization of pseudotype VSV possessing HCV envelope proteins. Virology 286:263-275.
19. Page, K.A., Landau, N.R., and Littman, D.R. 1990. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 64:5270-5276.
20. Pickl, W.F., Pimentel-Muinos, F.X., and Seed, B. 2001. Lipid rafts and pseudotyping. J. Virol. 75:7175-7183.
21. Plemper, R.K., Doyle, J., Sun, A., Prussia, A., Cheng, L.T., Rota, P.A., Liotta, D.C., Snyder, J.P., and Compans, R.W. 2005. Design of a small-molecule entry inhibitor with activity against primary measles virus strains. Antimicrob. Agents Chemother. 49:3755-3761.
22. Radoshitzky, S.R., Abraham, J., Spiropoulou, C.F., Kuhn, J.H., Nguyen, D., Li, W., Nagel, J., Schmidt, P.J., Nunberg, J.H., Andrews, N.C., Farzan, M., and Choe, H. 2007. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446:92-96.
23. Sanders, D.A. 2002. No false start for novel pseudotyped vectors. Curr. Opin. Biotechnol. 13:437-442.
24. Sharkey, C.M., North, C.L., Kuhn, R.J., and Sanders, D.A. 2001. Ross River virus glycoprotein-pseudotyped retroviruses and stable cell lines for their production. J. Virol. 75:2653-2659.
25. Smith, A.E. and Helenius, A. 2004. How viruses enter animal cells. Science 304:237-242.
26. Sung, V.M. and Lai, M.M. 2002. Murine retroviral pseudotype virus containing hepatitis B virus large and small surface antigens confers specific tropism for primary human hepatocytes: A potential liver-specific targeting system. J. Virol. 76:912-917.
27. Swanstrom, R. and Wills, J.W. 1997. Synthesis, assembly, and processing of viral proteins. In Retroviruses (J.M. Coffin, S.H. Hughes, and H.E. Varmus, eds.) pp. 263-334. Cold Spring Harbor Laboratory Press, New York.
28. Tang, J., Yang, T., Ghosh, H.P., and Geller, A.I. 2001. Helper virus-free HSV-1vectorspackaged both in the presence of VSV G protein and in the absence of HSV-1 glycoprotein B support gene transfer into neurons in the rat striatum. J. Neurovirol. 7:548-555.
29. Tilton, J.C. and Doms, R. W. 2010. Entry inhibitors in the treatment of HIV-1 infection. Antiviral Res. 85:91-100.
30. Vincent, M.J., Melsen, L.R., Martin, A.S., and Compans, R.W. 1999. Intracellular interaction of simian immunodeficiency virus Gag and Env proteins. J. Virol. 73:8138-8144.
31. Wang, W., Butler, E.N., Veguilla, V., Vassell, R., Thomas, J.T., Moos, M., Ye, Z., Hancock, K., and Weiss, C.D. 2008. Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies. J. Virol. Methods 153:111-119.
32. Wyma, D.J., Kotov, A., and Aiken, C. 2000. Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles. J. Virol. 74:9381-9387.
33. Yi, L., Li, Z., Yuan, K., Qu, X., Chen, J., Wang, G., Zhang, H., Luo, H., Zhu, L., Jiang, P., Chen, L., Shen, Y., Luo, M., Zuo, G., Hu, J., Duan, D., Nie, Y., Shi, X., Wang, W., Han, Y., Li, T., Liu, Y., Ding, M., Deng, H., and Xu, X. 2004. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J. Virol. 78:11334-11339.
34. Yu, Q., Chen, D., König, R., Mariani, R., Unutmaz, D., and Landau, N.R. 2004. APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J. Biol. Chem. 279:53379-53386.
35. Zampieri, C.A., Sullivan, N.J., and Nabel, G.J. 2007. Immunopathology of highly virulent pathogens: Insights from Ebola virus. Nat. Immunol. 8:1159-1164.
36. Zhang, J.H., Chung, T.D., and Oldenburg, K.R. 1999. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4:67-73.
37. Zhu, Z., Chen, S.S.L., and Huang, A.S. 1990. Phenotypic mixing between human immunodeficiency virus and vesicular stomatitis virus or herpes simplex virus. J. Acquired Immune Defic. Syndr. 3:215-219.